Terex (TEX) came out with quarterly earnings of $1.5 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.95%. A quarter ago, it was expected that this machinery products maker would post earnings of $1.44 per share when it actually produced earnings of $1.49, delivering a surprise of +3.47%.Over the last four quarters, the co ...

Core Viewpoint - Advanced Micro Devices Inc. (AMD) is highlighted as a strong growth stock for the next five years, with analysts maintaining positive ratings and setting ambitious price targets [1][2][3]. Group 1: Analyst Ratings and Price Targets - Rosenblatt Securities analyst Kevin Cassidy reiterated a Buy rating on AMD, setting a price target of $250.00 [1]. - Mizuho raised its price target on AMD to $275 from $205, maintaining an Outperform rating [2]. Group 2: Partnerships and Growth Potential - AMD announced a multi-year partnership with OpenAI to deploy 6GW of AMD GPUs for OpenAI's next-generation AI infrastructure, with the first phase involving 1GW scheduled to begin in H2 2026 [3]. - The partnership with OpenAI is estimated to be valued between $90 billion and $100 billion through 2030 [2]. Group 3: Company Overview and Market Segments - AMD operates as a semiconductor company globally, with three main segments: Data Center, Client and Gaming, and Embedded [4].

Micron Technology Inc. (NASDAQ:MU) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 20, Barclays analyst Tom O’Malley raised the firm’s price target on Micron to $240 from $195 and maintained an Overweight rating on the shares. Barclays is very selective when choosing companies that have direct exposure to AI due to recent stock price increases. O’Malley believes that many of these stocks are already pricing in the full benefit of future AI deployment. Earlier on October 17, ...

Vivian Tu, the former Wall Street trader turned personal finance creator behind Your Rich BFF, has built a massive following by making money advice actually useful. When economic downturns hit, her strategies for her audience shift from wealth-building mode to recession survival. For You: The One Dangerous Habit Keeping You in Credit Card Debt, According to Liz Claman Learn About: 3 Advanced Investing Moves Experts Use to Minimize Taxes and Help Boost Returns Here are the five money moves Tu recommends wh ...

DexCom Inc. (NASDAQ:DXCM) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 15, Truist analyst Richard Newitter lowered the firm’s price target on DexCom to $94 from $102 with a Buy rating on the shares as part of the firm’s broader research note previewing Q3 2025 results in the MedTech sector. The firm anticipates healthy revenue and earnings for Q3 across all companies it covers, but warns of stock volatility. Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Secto ...

Tree.com (TREE) came out with quarterly earnings of $1.7 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.8 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +38.21%. A quarter ago, it was expected that this mortgage lending service provider would post earnings of $0.97 per share when it actually produced earnings of $1.13, delivering a surprise of +16.49%.Over the last four qua ...

Core Insights - Insulet Corporation (NASDAQ:PODD) is identified as a top growth stock for the next five years, with RBC Capital raising its price target to $365 from $350, maintaining an Outperform rating due to attractive valuations and opportunities in the Medical Supplies & Devices sector [1][2][3] Company Overview - Insulet Corporation specializes in developing, manufacturing, and selling insulin delivery systems for individuals with insulin-dependent diabetes, both in the US and internationally [4] Market Sentiment - Investor sentiment is positive ahead of Insulet's Q3 earnings report, as management has indicated strong business momentum that is expected to exceed official Q3 guidance, reducing risk for the quarter [2][3] Industry Trends - The MedTech sector is experiencing steady adoption of continuous glucose monitors and insulin pumps, with significant opportunities identified in the Type 2 insulin-intensive market, which enhances Insulet's competitive position [3]

ASML Holding (NASDAQ:ASML) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 16, Berenberg raised the firm’s price target on ASML Holding to EUR 1,050 from EUR 735 with a Buy rating on the shares as ASML Holding’s Q3 2025 results confirmed the recent positive trend in the semiconductor equipment industry. Berenberg believes that the company is positioned to benefit from DRAM spend growth in 2026 and beyond. On the same day, Deutsche Bank also lifted the firm’s price target on ...

Core Insights - Apple is set to report earnings for its fiscal fourth quarter after the market closes on Thursday, following a significant increase in its market capitalization to $4 trillion [1] - Wall Street analysts are optimistic about iPhone demand, which is expected to be the main factor driving a report that exceeds consensus estimates [1] - Investors are advised to pay attention to updates regarding Apple's ambitions in artificial intelligence, as there are concerns that its major competitors are advancing more rapidly in this area [1]

Super Micro Computer Inc. (NASDAQ:SMCI) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 24, Super Micro Computer announced an expansion to its portfolio of Cloud Service Provider solutions with the new 6U 20-Node MicroBlade system, which incorporates the AMD EPYC 4005 Series Processors. The announcement highlights a solution optimized for performance, efficiency, and affordability, targeting Cloud Computing, Web Hosting, VDI/Virtual Desktop Infrastructure, AI Inference, and ...